{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:56:03Z","timestamp":1784598963345,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.braindev.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T23:05:49Z","timestamp":1450220749000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation"],"prefix":"10.1016","volume":"38","author":[{"given":"Chlo\u00e9","family":"Di Meglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bonello-Palot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Boulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Milh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ovaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Chabrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2015.11.006_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot\u2013Marie\u2013Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.braindev.2015.11.006_b0010","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1523\/JNEUROSCI.6248-09.2010","article-title":"Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the miro\/milton complex","volume":"30","author":"Misko","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.braindev.2015.11.006_b0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature07534","article-title":"Mitofusin 2 tethers endoplasmic reticulum to mitochondria","volume":"456","author":"de Brito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.braindev.2015.11.006_b0020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","article-title":"Diagnosis, natural history, and management of Charcot\u2013Marie\u2013Tooth disease","volume":"8","author":"Pareyson","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2015.11.006_b0025","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/brain\/awl174","article-title":"Early onset severe and late-onset mild Charcot\u2013Marie\u2013Tooth disease with mitofusin 2 (MFN2) mutations","volume":"129","author":"Chung","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0030","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.0b013e31821a441e","article-title":"MFN2 mutations cause severe phenotypes in most patients with CMT2A","volume":"76","author":"Feely","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2015.11.006_b0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","article-title":"Charcot\u2013Marie\u2013Tooth disease: frequency of genetic subtypes and guidelines for genetic testing","volume":"83","author":"Murphy","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2015.11.006_b0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet"},{"key":"10.1016\/j.braindev.2015.11.006_b0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0050","series-title":"GeneReviews\u2122 [Internet]","article-title":"Charcot\u2013Marie\u2013Tooth neuropathy type 2","author":"Bird","year":"1993"},{"key":"10.1016\/j.braindev.2015.11.006_b0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/01.wnl.0000168898.76071.70","article-title":"Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene","volume":"65","author":"Lawson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2015.11.006_b0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1385\/NMM:8:1-2:63","article-title":"Molecular genetics of autosomal-dominant axonal Charcot\u2013Marie\u2013Tooth disease","volume":"8","author":"Z\u00fcchner","year":"2006","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.braindev.2015.11.006_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/awr323","article-title":"The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy \u201cplus\u201d phenotype","volume":"135","author":"Rouzier","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","article-title":"Reliability and validity of the CMT neuropathy score as a measure of disability","volume":"64","author":"Shy","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2015.11.006_b0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.23572","article-title":"Validation of the Charcot\u2013Marie\u2013Tooth disease pediatric scale as an outcome measure of disability","volume":"71","author":"Burns","year":"2012","journal-title":"Ann Neurol"},{"issue":"e223","key":"10.1016\/j.braindev.2015.11.006_b0080","first-page":"1","article-title":"MFN2, a new gene responsible for mitochondrial DNA depletion","volume":"135","author":"Renaldo","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/geno.1993.1334","article-title":"Localization of a gene (CMT2A) for autosomal dominant Charcot\u2013Marie\u2013Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity","volume":"17","author":"Othmane","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.braindev.2015.11.006_b0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archneurol.2011.225","article-title":"Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria","volume":"68","author":"Klein","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2015.11.006_b0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2350-14-94","article-title":"Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies","volume":"14","author":"\u00d8stern","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.braindev.2015.11.006_b0100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.49.6.1630","article-title":"Linkage mapping of the gene for Charcot\u2013Marie\u2013Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A","volume":"49","author":"Saito","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2015.11.006_b0105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2169\/internalmedicine.51.6676","article-title":"Coenzyme Q10 therapy in hereditary motor sensory neuropathy type VI with novel mitofusin 2 mutation","volume":"51","author":"Takahashi","year":"2012","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.braindev.2015.11.006_b0110","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/jnnp.2009.181669","article-title":"Early-onset Charcot\u2013Marie\u2013Tooth patients with mitofusin 2 mutations and brain involvement","volume":"81","author":"Chung","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2015.11.006_b0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.braindev.2015.11.006_b0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.20797","article-title":"Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2","volume":"59","author":"Z\u00fcchner","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2015.11.006_b0125","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/brain\/awl126","article-title":"MFN2 mutation distribution and genotype\/phenotype correlation in Charcot\u2013Marie\u2013Tooth type 2","volume":"129","author":"Verhoeven","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0130","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/brain\/awr184","article-title":"Genetic spectrum of hereditary neuropathies with onset in the first year of life","volume":"134","author":"Baets","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s12264-014-1475-7","article-title":"Intermediate Charcot\u2013Marie\u2013Tooth disease","volume":"30","author":"Liu","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.braindev.2015.11.006_b0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2007.02.010","article-title":"GDAP1 mutations in Czech families with early-onset CMT","volume":"17","author":"Bar\u00e1nkov\u00e1","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2015.11.006_b0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e318228fc70","article-title":"Dominant GDAP1 mutations cause predominantly mild CMT phenotypes","volume":"77","author":"Zimo\u0144","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2015.11.006_b0150","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.0b013e318217e77d","article-title":"Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT","volume":"76","author":"Cassereau","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2015.11.006_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2008.01.010","article-title":"Mitochondrial fusion and function in Charcot\u2013Marie\u2013Tooth type 2A patient fibroblasts with mitofusin 2 mutations","volume":"211","author":"Amiott","year":"2008","journal-title":"Exp Neurol"},{"issue":"e224","key":"10.1016\/j.braindev.2015.11.006_b0160","first-page":"1","article-title":"Reply: MFN2, a new gene responsible for mitochondrial DNA depletion","volume":"135","author":"Rouzier","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2015.11.006_b0165","doi-asserted-by":"crossref","first-page":"293893","DOI":"10.1155\/2013\/293893","article-title":"Mitochondrial fusion proteins and human diseases","volume":"2013","author":"Ranieri","year":"2013","journal-title":"Neurol Res Int"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760415002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760415002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T20:00:37Z","timestamp":1537128037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760415002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0387760415002363"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2015.11.006","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}